Guadecitabine sodium is a potent DNA methyltransferase (DNMT) inhibitor. It affects IFN and cGAS-STING signaling pathways by inducing DNA hypomethylation, effectively promoting tumor immunogenicity, MHC antigen presentation, and inhibiting tumor proliferation.